Steris plc, IE00BFY8C754

STERIS Stock - Sunday background on infection-prevention specialist

21.06.2026 - 23:00:45 | ad-hoc-news.de

STERIS stock draws a Sunday background check as investors revisit the medical-technology group’s role in infection prevention, its market position and the latest consensus expectations in the absence of fresh ad-hoc news.

Steris plc, IE00BFY8C754
Steris plc, IE00BFY8C754

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 21:59 UTC. Details in the imprint.

STERIS (IE00BFY8C754) is a global provider of infection-prevention and procedural products for healthcare, pharmaceutical and research customers. With no new market-moving headlines confirmed on Sunday from primary sources, the focus shifts to a broader background look at the business and its leadership.

Go deeper

Background and price data on STERIS stock

All current articles, regulatory headlines and price data for STERIS stock are bundled on the ad hoc news topic page for this ISIN.

What recent filings show

STERIS last reported quarterly results for the fiscal fourth quarter ended 03/31/2024, posting revenue of about $1.43 billion and adjusted earnings per share around $2.58, according to its most recent IR release on quarterly earnings.

The company highlighted solid demand in healthcare, life sciences and dental markets in that update and pointed to continued integration of past acquisitions, including Cantel Medical, as a driver of scale and efficiencies in sterilization and infection-prevention offerings.

Background and leadership snapshot

STERIS traces its roots back several decades in the sterilization industry and has grown through targeted acquisitions into a diversified healthcare supplier with more than $5 billion in annual revenue, based on its latest full-year figures referenced in investor materials.

The group’s leadership team, headquartered in Dublin but with major operations in the United States, emphasizes recurring revenue from services and consumables tied to installed sterilization equipment, which can provide more predictable cash flows than one-off capital sales.

What the company sells

STERIS generates revenue from a mix of sterilizers, operating room equipment, endoscopy accessories, washers and disinfectants, along with related maintenance services and consumables, serving hospitals, surgery centers, pharmaceutical manufacturers and research laboratories worldwide.

Where the stock trades today

STERIS shares trade on the New York Stock Exchange under the ticker STE; the latest verified price data and intraday performance can be accessed on the main exchange or financial data platforms in US dollars.

Key facts on STERIS stock

  • Company: STERIS plc
  • ISIN: IE00BFY8C754
  • WKN: A14Q4Z
  • Ticker: STE
  • Venue: NYSE
  • Sector / Industry: Health Care / Medical Equipment
  • Index membership: S&P 500
  • Next earnings date: not officially scheduled

More on STERIS stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | IE00BFY8C754 | STERIS PLC | boerse | 69598965 | bgmi